Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology

The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumors

Heba Elsayd, Mahasen Abougabal, Maha Abdelkareem, Mohammed Houseni and Mai Hussein
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2705;
Heba Elsayd
1Kasr Alainy center of radiation oncology and nuclear medicine (NEMROCK)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahasen Abougabal
1Kasr Alainy center of radiation oncology and nuclear medicine (NEMROCK)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maha Abdelkareem
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed Houseni
2NLI, Menoufia University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mai Hussein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 2705

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Heba Elsayd,
  2. Mahasen Abougabal1,
  3. Maha Abdelkareem,
  4. Mohammed Houseni2 and
  5. Mai Hussein
  1. 1Kasr Alainy center of radiation oncology and nuclear medicine (NEMROCK)
  2. 2NLI, Menoufia University

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2022 to April 2025

AbstractFullPdf
Aug 2022500
Sep 20222600
Oct 20221600
Nov 20221800
Dec 2022500
Jan 20233700
Feb 20231800
Mar 20231500
Apr 20232700
May 20232900
Jun 20232100
Jul 20231300
Aug 20232400
Sep 20231500
Oct 20231400
Nov 20232700
Dec 20233300
Jan 20242600
Feb 20242800
Mar 20242100
Apr 20245900
May 20244000
Jun 20246900
Jul 202414800
Aug 202411100
Sep 20244600
Oct 20241800
Nov 20243000
Dec 20242100
Jan 20253000
Feb 20252500
Mar 20252400
Apr 20252800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumors
Heba Elsayd, Mahasen Abougabal, Maha Abdelkareem, Mohammed Houseni, Mai Hussein
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2705;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumors
Heba Elsayd, Mahasen Abougabal, Maha Abdelkareem, Mohammed Houseni, Mai Hussein
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2705;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Chimeric antigen receptor (CAR) T cells Imaging: Clinical Needs and Strategies for Success
  • Metastatic NUT Midline Carcinoma
  • Radionuclides used in Nuclear Therapeutic Medicine: a brief history, properties and main relevant studies of radionuclides with mass number less than 100
Show more Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire